Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease
Crossref DOI link: https://doi.org/10.1007/s10571-015-0327-y
Published Online: 2016-03-18
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saavedra, Juan M.
Funding for this research was provided by:
Department of Pharmacology and Physiology, Georgetown University
Text and Data Mining valid from 2016-03-01